EUROPEAN CONSENSUS TABLE ON THE USE OF BOTULINUM TOXIN TYPE A IN ADULT SPASTICITY


Wissel J., Ward A. B., Erztgaard P., Bensmail D., Hecht M. J., Lejeune T. M., ...Daha Fazla

JOURNAL OF REHABILITATION MEDICINE, cilt.41, sa.1, ss.13-25, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 1
  • Basım Tarihi: 2009
  • Doi Numarası: 10.2340/16501977-0303
  • Dergi Adı: JOURNAL OF REHABILITATION MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.13-25
  • Anahtar Kelimeler: botulinum toxin, upper motor neurone syndrome, adult spasticity, acquired brain injury, UPPER-LIMB SPASTICITY, TERM ELECTRICAL-STIMULATION, UPPER EXTREMITY SPASTICITY, QUALITY-OF-LIFE, DOUBLE-BLIND, SHOULDER PAIN, POSTSTROKE SPASTICITY, REDUCING SPASTICITY, COST-EFFECTIVENESS, FINGER SPASTICITY
  • İstanbul Üniversitesi Adresli: Evet

Özet

A group of clinicians from across Europe experienced in the use of botulinum toxin type a for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on best practice in managing adults with spasticity. this consensus table summarizes the current published data, which was collated following extensive literature searches, their assessment for level of evidence and discussion among the whole group. published information is supplemented by expert opinion based on clinical experience from 16 European countries, involving 28 clinicians, who treat an average of approximately 200 patients annually, representing many thousand spasticity treatments with botulinum toxin per year.